174 related articles for article (PubMed ID: 17005039)
21. Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.
Kelly-Hope LA; Unnasch TR; Stanton MC; Molyneux DH
Infect Dis Poverty; 2015; 4():36. PubMed ID: 26279835
[TBL] [Abstract][Full Text] [Related]
22. Final report of the Conference on the eradicability of Onchocerciasis.
Dadzie Y; Neira M; Hopkins D
Filaria J; 2003 Feb; 2(1):2. PubMed ID: 12605722
[TBL] [Abstract][Full Text] [Related]
23. Special intervention zones.
Yaméogo L
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():23-4. PubMed ID: 18718150
[TBL] [Abstract][Full Text] [Related]
24. Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in Ethiopia.
McPherson S; Tafese G; Tafese T; Behaksra SW; Solomon H; Oljira B; Miecha H; Debebe KA; Kebede B; Gebre T; Kebede F; Seife F; Tadesse F; Mammo B; Aseffa A; Solomon AW; Mabey DCW; Marks M; Gadisa E
EClinicalMedicine; 2023 May; 59():101984. PubMed ID: 37152362
[TBL] [Abstract][Full Text] [Related]
25. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
[TBL] [Abstract][Full Text] [Related]
26. Assessment and monitoring of onchocerciasis in Latin America.
Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
[TBL] [Abstract][Full Text] [Related]
27. The World Bank.
Bangoura O
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():31-3. PubMed ID: 18718152
[TBL] [Abstract][Full Text] [Related]
28. Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications.
Kyelem D; Sanou S; Boatin B; Medlock J; Coulibaly S; Molyneux DH
Ann Trop Med Parasitol; 2003 Dec; 97(8):827-38. PubMed ID: 14754495
[TBL] [Abstract][Full Text] [Related]
29. [Ivermectin].
Boussinesq M
Med Trop (Mars); 2005; 65(1):69-79. PubMed ID: 15903082
[TBL] [Abstract][Full Text] [Related]
30. Importance of ivermectin to human onchocerciasis: past, present, and the future.
Cupp EW; Mackenzie CD; Unnasch TR
Res Rep Trop Med; 2011; 2():81-92. PubMed ID: 30881181
[TBL] [Abstract][Full Text] [Related]
31. The challenge of establishing community-directed treatment with Mectizan in Uganda.
Okwero P
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S171-4. PubMed ID: 9861290
[TBL] [Abstract][Full Text] [Related]
32. Filariasis in Africa--treatment challenges and prospects.
Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
[TBL] [Abstract][Full Text] [Related]
33. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
[TBL] [Abstract][Full Text] [Related]
34. DISTRIBUTION AND UTILISATION OF IVERMECTIN (MECTIZAN): A CHEMOTHERAPEUTIC APPROACH TO THE CONTROL OF ONCHOCERCIASIS IN OLD OHAOZARA LGA, EBONYI STATE, EASTERN NIGERIA.
Okpara EM; Mnaemeka AM; Iyioku UU; Udoh UV
J Egypt Soc Parasitol; 2015 Dec; 45(3):663-70. PubMed ID: 26939245
[TBL] [Abstract][Full Text] [Related]
35. Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.
Thylefors B; Alleman MM; Twum-Danso NA
Trop Med Int Health; 2008 May; 13(5):689-96. PubMed ID: 18419585
[TBL] [Abstract][Full Text] [Related]
36. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
37. Onchocerciasis control: the APOC strategy.
Dadzie KY
Afr Health; 1997 Mar; 19(3):13-5. PubMed ID: 12292398
[TBL] [Abstract][Full Text] [Related]
38. Public-private partnerships in blindness prevention: reaching beyond the eye.
Molyneux DH; Nantulya V
Eye (Lond); 2005 Oct; 19(10):1050-6. PubMed ID: 16304584
[TBL] [Abstract][Full Text] [Related]
39. Elimination of onchocerciasis from Africa: possible?
Mackenzie CD; Homeida MM; Hopkins AD; Lawrence JC
Trends Parasitol; 2012 Jan; 28(1):16-22. PubMed ID: 22079526
[TBL] [Abstract][Full Text] [Related]
40. Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon.
Wanji S; Tendongfor N; Nji T; Esum M; Che JN; Nkwescheu A; Alassa F; Kamnang G; Enyong PA; Taylor MJ; Hoerauf A; Taylor DW
Parasit Vectors; 2009 Aug; 2(1):39. PubMed ID: 19712455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
